Combining both factors, the risk of recurrent gastric ulcer bleeding in co-morbid patients with weak SRF up-regulation increased by 8.29-fold (95% CI, 1.31~52.62; p = 0.03). This evidence concerns the gene SRF and gastric ulcer.